Literature DB >> 23354985

Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.

Ben Schöttker1, Christian Herder, Dietrich Rothenbacher, Laura Perna, Heiko Müller, Hermann Brenner.   

Abstract

Plausible mechanisms of how vitamin D deficiency may contribute to the development of diabetes mellitus have been proposed but longitudinal cohort studies have yielded heterogeneous results. In 7,791 initially diabetes-free participants of a German population-based cohort, aged 50-74 years, adjusted Cox regression models were employed to estimate hazard ratios (HR) with 95 % confidence intervals (CI) for the association of serum 25-hydroxyvitamin D (25(OH)D) quintiles and incident diabetes. Dose-response relationships were assessed with restricted cubic spline curves. Additionally, analyses accounting for the competing risks of diabetes and death were performed. During 8 years of follow-up, 829 study participants developed diabetes. In women, diabetes risk was significantly increased in the lowest 25(OH)D quintile (HR, 1.38; 1.09-1.75) and non-significantly increased in the 2nd quintile (HR, 1.24; 0.98-1.55) compared to women in 25(OH)D quintiles 3-5. The dose-response relationship showed a non-linear inverse association with risk starting to increase at 25(OH)D levels below 70 nmol/L (statistically significant: below 40 nmol/L). In men, 25(OH)D levels were not associated with diabetes incidence. Renal dysfunction was an effect modifier with a more than doubled diabetes risk in 25(OH)D quintile 1 and an about 1.5-fold risk in quintile 2 compared to quintiles 3-5 if subjects had renal dysfunction. The observed associations were not influenced by the competing risk of death. In this large cohort study of older adults, serum 25(OH)D levels were inversely associated with incident diabetes in women but not in men. The association was particularly strong in subjects with renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354985     DOI: 10.1007/s10654-013-9769-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  46 in total

1.  Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.

Authors:  Ronald B Geskus
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

2.  Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study.

Authors:  Enju Liu; James B Meigs; Anastassios G Pittas; Christina D Economos; Nicola M McKeown; Sarah L Booth; Paul F Jacques
Journal:  Am J Clin Nutr       Date:  2010-04-14       Impact factor: 7.045

Review 3.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

Review 4.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.

Authors:  Margherita T Cantorna; Yan Zhu; Monica Froicu; Anja Wittke
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

Review 5.  Vitamin D and the immune system: new perspectives on an old theme.

Authors:  Martin Hewison
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

Review 6.  Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies.

Authors:  N G Forouhi; Z Ye; A P Rickard; K T Khaw; R Luben; C Langenberg; N J Wareham
Journal:  Diabetologia       Date:  2012-04-15       Impact factor: 10.122

7.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

Authors:  B Payson Oberg; Elizabeth McMenamin; F Lee Lucas; Ellen McMonagle; Jason Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

8.  Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach.

Authors:  Elke Raum; Dietrich Rothenbacher; Michael Löw; Christa Stegmaier; Hartwig Ziegler; Hermann Brenner
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-12

9.  Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study.

Authors:  Barbara Thorand; Astrid Zierer; Cornelia Huth; Jakob Linseisen; Christa Meisinger; Michael Roden; Annette Peters; Wolfgang Koenig; Christian Herder
Journal:  Diabetes Care       Date:  2011-08-26       Impact factor: 19.112

10.  Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.

Authors:  Nita G Forouhi; Jian'an Luan; Andrew Cooper; Barbara J Boucher; Nicholas J Wareham
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

View more
  28 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Vitamin D and glycemic control in diabetes mellitus type 2.

Authors:  Ifigenia Kostoglou-Athanassiou; Panagiotis Athanassiou; Anastasios Gkountouvas; Philippos Kaldrymides
Journal:  Ther Adv Endocrinol Metab       Date:  2013-08       Impact factor: 3.565

3.  The Generation R Study: Biobank update 2015.

Authors:  Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

4.  Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health?

Authors:  Ben Schöttker; Kai-Uwe Saum; Laura Perna; José Manuèl Ordóñez-Mena; Bernd Holleczek; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2014-03-29       Impact factor: 8.082

5.  Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study.

Authors:  Brian Buijsse; Heiner Boeing; Frank Hirche; Cornelia Weikert; Matthias B Schulze; Marion Gottschald; Tilman Kühn; Verena A Katzke; Birgit Teucher; Jutta Dierkes; Gabriele I Stangl; Rudolf Kaaks
Journal:  Eur J Epidemiol       Date:  2013-09-04       Impact factor: 8.082

6.  1α,25-Dihydroxyvitamin D3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice.

Authors:  Yi Xiong; Yixin Zhang; Na Xin; Ying Yuan; Qin Zhang; Ping Gong; Yingying Wu
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

Review 7.  Association of Hypovitaminosis D with Metabolic Syndrome in Postmenopausal Women.

Authors:  Kavita Agarwal; Manjula Sharma
Journal:  J Obstet Gynaecol India       Date:  2020-04-25

Review 8.  Early origins of chronic obstructive lung diseases across the life course.

Authors:  Liesbeth Duijts; Irwin K Reiss; Guy Brusselle; Johan C de Jongste
Journal:  Eur J Epidemiol       Date:  2014-12-24       Impact factor: 8.082

9.  Vitamin D levels and cognition in elderly adults in China.

Authors:  Choy-Lye Chei; Prassanna Raman; Zhao-Xue Yin; Xiao-Ming Shi; Yi Zeng; David B Matchar
Journal:  J Am Geriatr Soc       Date:  2014-10-03       Impact factor: 5.562

10.  SERUM 25-HYDROXYVITAMIN D(3) LEVELS IN TYPE 2 DIABETIC PATIENTS WITH NORMO-, MICRO-, AND MACROALBUMINURIA.

Authors:  F Sari; S Ozdem; R Sari
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.